These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34958044)

  • 1. Stride Velocity 95th Centile: Insights into Gaining Regulatory Qualification of the First Wearable-Derived Digital Endpoint for use in Duchenne Muscular Dystrophy Trials.
    Servais L; Yen K; Guridi M; Lukawy J; Vissière D; Strijbos P
    J Neuromuscul Dis; 2022; 9(2):335-346. PubMed ID: 34958044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stride Velocity 95th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular Dystrophy.
    Rabbia M; Guridi Ormazabal M; Staunton H; Veenstra K; Eggenspieler D; Annoussamy M; Servais L; Strijbos P
    J Neuromuscul Dis; 2024; 11(3):701-714. PubMed ID: 38640165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European regulators' views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials.
    Haberkamp M; Moseley J; Athanasiou D; de Andres-Trelles F; Elferink A; Rosa MM; Magrelli A
    Neuromuscul Disord; 2019 Jul; 29(7):514-516. PubMed ID: 31272741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases.
    Servais L; Camino E; Clement A; McDonald CM; Lukawy J; Lowes LP; Eggenspieler D; Cerreta F; Strijbos P
    Digit Biomark; 2021; 5(2):183-190. PubMed ID: 34723071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environment.
    Poleur M; Ulinici A; Daron A; Schneider O; Farra FD; Demonceau M; Annoussamy M; Vissière D; Eggenspieler D; Servais L
    Orphanet J Rare Dis; 2021 Jul; 16(1):318. PubMed ID: 34281599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball.
    Mori H; Wiklund SJ; Zhang JY
    Digit Biomark; 2022; 6(2):36-46. PubMed ID: 35949224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of shoe-worn Gait Up Physilog®5 wearable inertial sensors in adolescents.
    Carroll K; Kennedy RA; Koutoulas V; Bui M; Kraan CM
    Gait Posture; 2022 Jan; 91():19-25. PubMed ID: 34628218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy.
    Gidaro T; Gasnier E; Annoussamy M; Vissing J; Attarian S; Mozaffar T; Iyadurai S; Wagner KR; Vissière D; Walker G; Shukla SS; Servais L
    Muscle Nerve; 2022 Feb; 65(2):237-242. PubMed ID: 34687225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.
    Kennedy RA; Carroll K; McGinley JL; Paterson KL
    J Foot Ankle Res; 2020 Mar; 13(1):10. PubMed ID: 32122377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal community walking activity in Duchenne muscular dystrophy.
    Fowler EG; Staudt LA; Heberer KR; Sienko SE; Buckon CE; Bagley AM; Sussman MD; McDonald CM
    Muscle Nerve; 2018 Mar; 57(3):401-406. PubMed ID: 28692198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gait assessment in children with duchenne muscular dystrophy during long-distance walking.
    Ganea R; Jeannet PY; Paraschiv-Ionescu A; Goemans NM; Piot C; Van den Hauwe M; Aminian K
    J Child Neurol; 2012 Jan; 27(1):30-8. PubMed ID: 21765150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy.
    Ricotti V; Kadirvelu B; Selby V; Festenstein R; Mercuri E; Voit T; Faisal AA
    Nat Med; 2023 Jan; 29(1):95-103. PubMed ID: 36658421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring Gait Velocity and Stride Length with an Ultrawide Bandwidth Local Positioning System and an Inertial Measurement Unit.
    Singh P; Esposito M; Barrons Z; Clermont CA; Wannop J; Stefanyshyn D
    Sensors (Basel); 2021 Apr; 21(9):. PubMed ID: 33919056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson's Patients Using Digital Mobility Outcomes.
    Viceconti M; Hernandez Penna S; Dartee W; Mazzà C; Caulfield B; Becker C; Maetzler W; Garcia-Aymerich J; Davico G; Rochester L
    Sensors (Basel); 2020 Oct; 20(20):. PubMed ID: 33092143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.
    Gissy JJ; Johnson T; Fox DJ; Kumar A; Ciafaloni E; van Essen AJ; Peay HL; Martin A; Lucas A; Finkel RS;
    Neuromuscul Disord; 2017 Oct; 27(10):905-910. PubMed ID: 28739181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gait in Duchenne Muscular Dystrophy: Relation of 3D gait analysis to clinical assessment.
    Romano A; Favetta M; Schirinzi T; Summa S; Minosse S; D'Amico A; Catteruccia M; Petrarca M; Castelli E; Bertini E; Vasco G
    Neuromuscul Disord; 2019 Dec; 29(12):920-929. PubMed ID: 31791868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wearable sensor-based in-home assessment of gait, balance, and physical activity for discrimination of frailty status: baseline results of the Arizona frailty cohort study.
    Schwenk M; Mohler J; Wendel C; D'Huyvetter K; Fain M; Taylor-Piliae R; Najafi B
    Gerontology; 2015; 61(3):258-67. PubMed ID: 25547185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of muscular co-activation and gait variability in children with Duchenne muscular dystrophy: A 2-year follow-up study.
    Rinaldi M; Petrarca M; Romano A; Vasco G; D'Anna C; Bibbo D; Schmid M; Castelli E; Conforto S
    Clin Biomech (Bristol, Avon); 2020 Aug; 78():105101. PubMed ID: 32652381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.